Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 14/20 | 0.39 |
| ▸ | PSMB8 | P28062 | 1/20 | 0.36 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.36 |
| ▸ | MAOA | P21397 | 3/20 | 0.35 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.34 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.33 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | PTGES | O14684 | 1/20 | 0.33 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.33 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9764914 | 0.98 | MAOB (0.40) | MAOBPSMB8PSMB5MAOAADORA2B | |
| SCHEMBL9764908 | 0.85 | MAOB (0.39) | MAOBMAOAADORA2BMAPTNISCH | |
| SCHEMBL9764896 | 0.84 | MAOB (0.38) | MAOBMAOAADORA2BMAPTNISCH | |
| SCHEMBL10560471 | 0.83 | MAOB (0.37) | MAOBPSMB8PSMB5ADORA2BKDM4C | |
| SCHEMBL9764869 | 0.83 | MAOB (0.37) | MAOBPSMB8PSMB5ADORA2BKDM4C | |
| SCHEMBL9764903 | 0.82 | MAOB (0.42) | MAOBPSMB8PSMB5KDM4CMAPT | |
| SCHEMBL10609848 | 0.82 | MAOB (0.40) | MAOBPSMB8PSMB5MAOAKDM4C | |
| SCHEMBL9764835 | 0.81 | MAOB (0.41) | MAOBMAOAPTPN1MAPTPTGES | |
| SCHEMBL9764894 | 0.79 | MAOB (0.36) | MAOBPSMB8PSMB5MAOAADORA2B | |
| SCHEMBL9764879 | 0.76 | CA2 (0.39) | MAOBPSMB8PSMB5MAOAKDM4C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0422079-A4 | TRICYCLIC LIPOXYGENASE INHIBITING COMPOUNDS, COMPOSITIONS, METHODS OF USE | — | 1991-08-21 | — | — | EP | disclosed |
| EP-0422079-A1 | TRICYCLIC LIPOXYGENASE INHIBITING COMPOUNDS, COMPOSITIONS, METHODS OF USE | ABBOTT LABORATORIES (US) | 1991-04-17 | — | — | EP | disclosed |
| WO-1989012636-A1 | TRICYCLIC LIPOXYGENASE INHIBITING COMPOUNDS, COMPOSITIONS, METHODS OF USE | ABBOTT LABORATORIES (US) | 1989-12-28 | — | — | WO | disclosed |
| EP-0346939-A1 | Tricyclic lipoxygenase inhibiting compounds | ABBOTT LABORATORIES (US) | 1989-12-20 | — | — | EP | disclosed |
| US-4822811-A | Carbazole lipoxygenase inhibiting compounds, compositions and use | ABBOTT LABORATORIES (US) | 1989-04-18 | — | — | US | disclosed |
| US-4769387-A | Dibenzofuran lipoxygenase inhibiting compounds, compositions and use | ABBOTT LABORATORIES (US) | 1988-09-06 | — | — | US | disclosed |